Method of preventing retinopathy of prematurity in a neonate
CA 2377453 A1 · Owner: Farmacon-Il, Llc · Inventors: Van Omermeire, Bart; Darko, Laszlo
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method is disclosed of preventing retinopathy of prematurity in a prematurely born neonate susceptible to developing retinopathy of prematurity, which comprises the step of parenterally administering to said prematurely born neonate a, therapeutically effective amount of a water-soluble pharmaceutically effective salt of ibuprofen as an active ingredient to promote retinal and choroidal blood flow autoregulation in said neonate.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 19, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 19, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 19, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.